Literature DB >> 21506056

Reducing mortality in severe sepsis and septic shock.

Andrew T Levinson1, Brian P Casserly, Mitchell M Levy.   

Abstract

Severe sepsis is one of the most common reasons for critically ill patients to be admitted to an intensive care unit (ICU) and has very high associated morbidity and mortality. The Surviving Sepsis Campaign was initiated with the hope that mortality might be reduced by standardizing care informed by data from an increasing number of clinical trials. Important methods for reducing mortality identified by recent studies include aggressive fluid resuscitation, early goal-directed therapy (EGDT), early administration of antibiotics, and the administration of activated protein C to eligible patients. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506056     DOI: 10.1055/s-0031-1275532

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  11 in total

Review 1.  Platelet function beyond hemostasis and thrombosis.

Authors:  Jerry Ware; Adam Corken; Reshma Khetpal
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

2.  Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.

Authors:  Brian M Peters; Mairi C Noverr
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

3.  The continuing question of how fever duration is associated with patient outcome.

Authors:  Panagiotis Kiekkas; Diamanto Aretha; George I Baltopoulos
Journal:  Crit Care       Date:  2012-11-09       Impact factor: 9.097

4.  Prognostic usefulness of eosinopenia in the pediatric intensive care unit.

Authors:  Yoon Hee Kim; Hyun Bin Park; Min Jung Kim; Hwan Soo Kim; Hee Seon Lee; Yoon Ki Han; Kyung Won Kim; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

5.  Eosinopenia as a Marker of Outcome in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Mohammad Hossein Rahimi-Rad; Behzad Asgari; Negar Hosseinzadeh; Ali Eishi
Journal:  Maedica (Buchar)       Date:  2015-03

6.  Hyperresponsiveness of mice deficient in plasma-secreted sphingomyelinase reveals its pivotal role in early phase of host response.

Authors:  Nayla Jbeily; Iris Suckert; Falk A Gonnert; Benedikt Acht; Clemens L Bockmeyer; Sascha D Grossmann; Markus F Blaess; Anja Lueth; Hans-Peter Deigner; Michael Bauer; Ralf A Claus
Journal:  J Lipid Res       Date:  2012-12-10       Impact factor: 5.922

7.  Sepsis-associated acute kidney injury - is it possible to move the needle against this syndrome?

Authors:  Prasad Devarajan; Rajit K Basu
Journal:  J Pediatr (Rio J)       Date:  2016-10-13       Impact factor: 2.197

Review 8.  The Neutrophil: Constant Defender and First Responder.

Authors:  Noah Fine; Nikola Tasevski; Christopher A McCulloch; Howard C Tenenbaum; Michael Glogauer
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

9.  Predictors of unattempted central venous catheterization in septic patients eligible for early goal-directed therapy.

Authors:  David R Vinson; Dustin W Ballard; Matthew D Stevenson; Dustin G Mark; Mary E Reed; Adina S Rauchwerger; Uli K Chettipally; Steven R Offerman
Journal:  West J Emerg Med       Date:  2014-02

10.  A prospective observational study assessing the outcome of Sepsis in intensive care unit of a tertiary care hospital, Peshawar.

Authors:  Arslan Rahat Ullah; Arshad Hussain; Iftikhar Ali; Abdul Samad; Syed Tajammul Ali Shah; Muhammad Yousef; Tahir Mehmood Khan
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.